Progesterone is the hormone that makes pregnancy possible and sustains it from the earliest days through delivery. Without adequate progesterone, a fertilized egg cannot implant, the uterine lining breaks down, and the pregnancy ends. Its roles expand as pregnancy progresses: preparing the uterus, calming uterine muscles, shielding the embryo from the mother’s immune system, and readying the breasts to produce milk.
How Progesterone Prepares the Uterus for Implantation
After ovulation each month, a temporary structure in the ovary called the corpus luteum begins pumping out progesterone. This hormone triggers a sweeping transformation of the uterine lining called decidualization. Cells in the lining shift from a thin, relatively inactive state into a thick, nutrient-rich tissue capable of receiving an embryo. Progesterone dials down genes involved in inflammation and tissue resistance while turning up genes that promote cell growth, blood vessel formation, and immune tolerance. It also stimulates the lining to secrete glycogen and other substances the embryo needs in its first days before a placenta forms.
If no embryo implants, the corpus luteum breaks down, progesterone drops, and the lining sheds as a menstrual period. If implantation succeeds, the corpus luteum keeps producing progesterone to maintain that lining. This is a critical window. Between the seventh and ninth week of pregnancy, a major transition occurs: the placenta gradually takes over progesterone production from the corpus luteum. During this overlap period, sometimes called the luteal-placental shift, both structures contribute progesterone. Once the placenta is fully in charge, progesterone levels climb steadily for the rest of pregnancy.
Progesterone Levels Through Each Trimester
Progesterone levels rise dramatically as pregnancy advances. Normal ranges, measured in nanograms per milliliter (ng/mL), give a sense of the scale:
- First trimester: 10 to 44 ng/mL
- Second trimester: 19.5 to 82.5 ng/mL
- Third trimester: 65 to 290 ng/mL
That final range represents roughly a six- to twenty-fold increase from early pregnancy. The placenta drives this surge, producing more progesterone as it grows larger and the demands of pregnancy increase.
Keeping the Uterus Calm and Preventing Early Labor
The uterus is a muscular organ, and those muscles are capable of powerful contractions. During pregnancy, premature contractions could push the baby out far too early. Progesterone acts as a natural muscle relaxant for the uterus through a mechanism sometimes called “progesterone block.” It raises the resting electrical potential of uterine muscle cells, making them less likely to fire and contract. Think of it as keeping the muscle in a deeply relaxed state.
This calming effect is strongest in early pregnancy and gradually decreases as the due date approaches. Near the end of pregnancy, the balance between progesterone and contraction-promoting signals (like oxytocin and prostaglandins) shifts, allowing labor to begin. The timing of that shift matters enormously. If progesterone’s calming influence weakens too soon, the result can be preterm labor.
Protecting the Pregnancy From the Immune System
An embryo carries DNA from both parents, which means half of its genetic material is foreign to the mother’s body. Under normal circumstances, the immune system would attack foreign tissue. Progesterone helps prevent this by triggering immune cells to release a protein called progesterone-induced blocking factor, or PIBF. This protein adjusts the behavior of key immune cells, specifically a type of white blood cell involved in coordinating immune responses. PIBF nudges these cells toward tolerance rather than attack, creating an environment where the pregnancy can grow without being rejected.
Women with healthy pregnancies have higher PIBF levels than women who go on to miscarry. When progesterone drops, PIBF drops with it, and the immune system’s protective tolerance can weaken. This connection between progesterone, PIBF, and immune regulation is one reason low progesterone in early pregnancy is closely linked to pregnancy loss.
Preparing the Breasts for Milk Production
Progesterone plays a specific and essential role in breast development during pregnancy. While estrogen stimulates the initial growth of milk ducts, progesterone is responsible for the next stage: branching of those ducts and the formation of small sac-like structures called alveoli where milk is actually produced. Without progesterone receptors, breast tissue fails to develop these milk-producing structures even when every other pregnancy hormone is present.
Interestingly, progesterone doesn’t need to act on every breast cell directly. It works through a relay system, signaling to a subset of cells in the ducts, which then release chemical messages to neighboring cells, prompting them to proliferate and form alveoli. This paracrine signaling means a relatively small number of progesterone-responsive cells can orchestrate the transformation of an entire breast into a milk-producing organ. After delivery, the sharp drop in progesterone is actually one of the signals that allows milk production to begin in earnest.
Low Progesterone and Miscarriage Risk
There is strong and consistent evidence linking low progesterone to first-trimester miscarriage. A large scoping review examining 23 studies found that every one of them reported a significant positive relationship between progesterone deficiency and early pregnancy loss. Low progesterone levels between weeks 6 and 10 are particularly predictive.
A serum progesterone level below roughly 11 ng/mL (35 nmol/L) before week 16 has been identified as a useful cutoff for predicting miscarriage risk. In one study, the miscarriage rate among women below that threshold was over 70%, even with hormonal treatment. Women with progesterone levels well above that cutoff had far better outcomes and generally did not need intervention. This doesn’t mean low progesterone always causes miscarriage. In some cases, the falling progesterone is a consequence of an already-failing pregnancy rather than the cause. But the two are tightly linked, and progesterone measurement in early pregnancy is one tool clinicians use to assess viability.
Progesterone Supplementation in Pregnancy
Because of progesterone’s central role, supplementation is sometimes used in early pregnancy, particularly for women undergoing fertility treatments or those with a history of recurrent loss. The most common scenario where progesterone is prescribed later in pregnancy involves preventing preterm birth.
Current guidance from the American College of Obstetricians and Gynecologists is specific about when vaginal progesterone is appropriate: it may be considered for women with a history of preterm birth who currently have a shortened cervix in a singleton pregnancy. Without a shortened cervix, vaginal progesterone has not been shown to reduce recurrence of preterm birth and is not recommended as a standalone prevention strategy. Women with a prior preterm birth are typically monitored with serial ultrasound measurements of cervical length, and treatment decisions are made based on those measurements along with individual history.
This nuance matters because progesterone supplementation is not a blanket solution for all preterm birth risk. Its effectiveness depends on the specific clinical picture, particularly whether the cervix is shortening prematurely.